Largest Pharma Manufacturing facility in Sri Lanka

Morison PLC, the largest oral solid dosage pharmaceutical manufacturer in Sri Lanka and a subsidiary of Hemas Holdings PLC, has invested a total of USD 18.5 million for the new Research and Manufacturing facility.

The new state-of-the-art manufacturing plant and research & development facility is located within the Sri Lanka Institute of Nano Technology (SLINTEC) Park in Homagama. It is the first European Union-Good Manufacturing Practice (EU-GMP) compliant oral solid dosage manufacturing plant in Sri Lanka.

Morison PLC, ceremonially opened their new state-of-the-art manufacturing plant and research & development facility in the presence of Honourable Prime Minister Mahinda Rajapaksa on the 02nd of October 2020. Several Cabinet Ministers and dignitaries also graced the event as special guests, including Minister of Health, Hon Pavithra Wanniarachchi; State Minister of Production, Supply and Regulation of Pharmaceuticals, Prof. Channa Jayasumana. Located within the Sri Lanka Nano Technology Park in Pitipana, Homagama this is the second manufacturing facility of Morison PLC.

The facility is ready to commence validation batches and is expected to start commercial production in early 2021, supporting the Government’s aim to manufacture essential medicines locally.

Morison is committed to increase access of high quality, affordable medicines to all Sri Lankans and enables it with the new plant, with a capacity to supply over 20% of Sri Lanka’s tablet needs. A pioneer in the local manufacture of pharmaceuticals, Morison’s new facility reaches a major milestone in Sri Lanka, being the first European Union-Good Manufacturing Practice (EU-GMP) compliant oral solid dosage manufacturing plant in Sri Lanka.

Morison produces 75 different formulations of medicine and intends to grow that portfolio in the coming years to address Sri Lanka’s growing medicinal needs, especially in the sphere of non-communicable diseases. The new plant has an annual production capacity of 5 billion tablets and 10 million bottles of medicine working at peak capacity on double shift, and aims to improve employment opportunities with the creation of 250 skilled jobs. The strength of the factory lies not only in its manufacturing capabilities. It also lies in its ability to create more skilled jobs and uplift the Homagama community through exposure of pharmaceutical sciences to the schools in the area and by working with higher educational institutions for internships and joint research.

The new plant is designed for minimum human intervention to prevent human error and includes cutting edge equipment such as the fully automated liquid manufacturing and packing lines, fully-fledged chemical and microbiology labs, separate air handling units to control environment conditions and is also equipped with Enterprise Resource Planning software. The plant also has the first zero liquid discharge waste water systems in the country.


Latest Technology

Fully automated tablet & liquid manufacturing lines with HMI, PLC controlled interfaces and compliance with 21CFR 11.


Quality Systems & In house Compliance

Run by a qualified and experienced team of employees, our fully-fledged Chemical and Microbiology laboratory at Morison is capable of testing all required tests as per Pharmacopoeia which is governed by a robust quality process that ensures our manufacturing procedure and the manufactured solutions are of prime quality.

To further enhance the quality of our manufactured medications, we take special care in sourcing the raw materials through pre-approved suppliers that are being tested as per Pharmacopeia ( BP / USP/ IP ) complying with the requirements of pharmacopoeia.

Products

Pharma Therapeutic Classes

  • Analgesic/Non Steroid Anti- inflammatory Drug(NSAIDS)
  • Bronchodialator/Beta 2 –adrenoreceptor agonist
  • Glucocorticoid /immunosuppressant
  • Sulfonylurea/ Anti- Diabetic
  • Sedative Antihistamine/Histamine H1 Receptor Antagonist
  • Antiemetic, Dopermine receptor antagonist
  • Antacid and Antifatulent
  • Cephalosporin antibiotic
  • Vitamins and Minerals
  • Antiseptic Mouth Wash
  • Anti-diabetic/ Biguanide
  • Bronchodilator, Xanthines
  • Angiotensin II Receptor Antagonists.
  • Lipid Regulating Drug
  • Antiseptic
  • Imidazole Antibacterial
  • Analgesic/Anti pyretic
  • Topical Antiseptic
  • Bronchodilator Mucolytic
  • Non-Sedating Antihistamine/Histamine H1 Receptor Antagonist
  • Antifungal
  • Mild antacid, Anti fatulent
  • Vitamins
  • Calcium and Vitamin D supplement
  • Sedative Anti-histamine
  • Non Sedative Anti-histamine
  • Osmotic Laxative
  • Antacid/ Proton pump inhibitor
  • Anti-itchings, astringents, anti-inflammatory agents
  • Antacid with Local Anesthetic
  • Antibacterial
  • Antiasthmatic
  • Anti-inflammatory
  • Antihypertensive
  • Diuretic
  • Antibacterials

Existing Products

Buyback

The buyback is a signed agreement with Medical supplies division which signed and initiated on the year 2014 and at present, Morison PLC is one of the largest manufacturers in the Buyback Scheme.

Tender

SPC are open tenders which Supply to all the distribution channels of State Pharmaceuticals Corporation, and Morison PLC is one of the largest local suppliers in Tender Business in Sri Lanka as of present.

Innovative Molecules

Inhouse NPD

As a progressive company with a vision to address all health issues by providing accessible medical solutions, Morison’s in-house New Product Development (NPD) unit, continuously explores and experiments to deliver new product solutions aligned.

The NPD at Morison is responsible for the entire process of taking a product or service from concept to market, passing through a series of stages that new products typically go through, beginning with ideation, concept generation and ending with introducing the product to the market and to grow the market consistently.

Strategic Sourcing

Technological Partnership